Global Prevalence of Asthma in Adults with Atopic Dermatitis and the Atopic Dermatitis–Asthma Association
Open Access
- 24 July 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (8) , 1149
Abstract
Background: Atopic dermatitis (AD) and asthma are common type 2 inflammatory diseases linked by the atopic march. In adults with AD, the prevalence of comorbid asthma and the strength of the AD–asthma association remain uncertain, with marked heterogeneity across studies. Moreover, the role of modern systemic therapies in this comorbidity is increasingly debated. Objective: To estimate the global pooled prevalence of asthma in adults with AD, quantify the AD–asthma association, and discuss the potential impact of targeted therapies (dupilumab, abrocitinib, omalizumab) on asthma comorbidity. Methods: Systematic review and random-effects meta-analysis (ID CRD420261304804) of observational studies from PubMed, EMBASE, and Cochrane Library (inception to 19 January 2026). Pooled prevalence and odds ratios (ORs) were calculated, with subgroup analyses by region, ethnicity, and disease definition. Results: Seventy-five studies were included. The global pooled prevalence of asthma in adults with AD was 25.9% (95% CI 22.1–30.0%; I2 = 99.9%). AD was significantly associated with asthma (OR 3.64, 95% CI 2.89–4.57; I2 = 98.6%). Prevalence varied from 9.3% in Asia to 63.2% in South America. Although dupilumab and other targeted agents are effective in both diseases, isolated reports of new-onset asthma after treatment were identified; these cases more likely reflect the natural progression of AD or unmasking of pre-existing asthma than a direct adverse drug reaction. Conclusions: Asthma is highly prevalent in adults with AD and is strongly associated with AD. Geographic and ethnic disparities call for stratified screening. Clinicians should be aware that new-onset respiratory symptoms during targeted therapy may represent AD-related comorbidity rather than drug-induced asthma.Keywords
This publication has 60 references indexed in Scilit:
- Incidence and Remission of Atopic Dermatitis in a German Birth CohortJAMA Network Open, 2025
- Predictors of Flares and Disease Severity in Patients With Atopic Dermatitis Using Machine LearningJAMA Dermatology, 2025
- Phenotypes of Atopic Dermatitis and Development of Allergic DiseasesJAMA Network Open, 2025
- Race-Specific and Race-Neutral Equations for Lung Function and Asthma Diagnosis in Black ChildrenJAMA Network Open, 2025
- Drug Survival of Dupilumab, Methotrexate, and Cyclosporine A in Children With Atopic DermatitisJAMA Dermatology, 2025
- Parental E-Cigarette Use and Pediatric Atopic DermatitisJAMA Dermatology, 2024
- Association of Atopic Dermatitis and Mental Health Outcomes Across ChildhoodJAMA Dermatology, 2021
- Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic DermatitisJAMA Dermatology, 2019
- Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in ChildhoodJAMA Dermatology, 2019
- Development of Atopic Dermatitis During the First 3 Years of LifeArchives of Dermatology, 2006